EPISODE · Jul 11, 2023 · 12 MIN
FDA Approves Leqembi: What You Should Know
from CareTalk: Healthcare. Unfiltered. · host CareTalk: Healthcare. Unfiltered.
Send us Fan MailFDA just approved Leqembi, a drug to slow the cognitive decline of Alzheimer’s patients, and Medicare has agreed to pay for it. Is it time for patients, families and physicians to be excited? Or do we need to temper our hopes?Dive deeper into this episode and read our report, Leqembi: What to Know About the New Alzheimer's Drug. https://www.caretalkpodcast.com/post/leqembi-what-to-know-about-the-new-alzheimer-s-drugABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.GET IN TOUCHBecome a CareTalk sponsorGuest appearance requestsVisit us on the webFOLLOW CARETALKSpotifyApple PodcastsGoogle PodcastsFollow us on LinkedIn#leqembi #alzheimers #pharma #FDA #medicare #medicaid #aduhelmSupport the show⚙️CareTalk: Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.
Embed this episode
What this episode covers
Send us Fan Mail FDA just approved Leqembi, a drug to slow the cognitive decline of Alzheimer’s patients, and Medicare has agreed to pay for it. Is it time for patients, families and physicians to be excited? Or do we need to temper our hopes? Dive deeper into this episode and read our report, Leqembi: What to Know About the New Alzheimer's Drug. https://www.caretalkpodcast.com/post/leqembi-what-to-know-about-the-new-alzheimer-s-drug ABOUT CARETALK CareTalk is a weekly podcast that provides...
NOW PLAYING
FDA Approves Leqembi: What You Should Know
No transcript for this episode yet
Similar Episodes
No similar episodes found.